TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18538965

Group type: EXPERIMENTAL
Intervention: Patient-held health records
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual follow-up
Number of subjects: 0
Study: 16344059

Group type: EXPERIMENTAL
Intervention: Eradication therapy
Number of subjects: 2324

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2324
Study: 14696818

Group type: EXPERIMENTAL
Intervention: Pathway 2 (new pathway incorporating semi‐quantitative cTnT measurement)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Pathway 1 (existing chest pain care pathway)
Number of subjects: 200
Study: 10934892

Group type: EXPERIMENTAL
Intervention: Salmeterol (50 micrograms BID)
Number of subjects: 634
Study: 8941107

Group type: EXPERIMENTAL
Intervention: Carvedilol at 50 to 100 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metoprolol at 125 to 150 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0
Study: 1399423

Group type: EXPERIMENTAL
Intervention: Computerized method of optic nerve head pallor measurement
Number of subjects: 30

Group type: COMPARATOR
Intervention: Manual boundary tracking
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Computerized method
Number of subjects: 30

Group type: COMPARATOR
Intervention: Manual method
Number of subjects: 30
Study: 4002801

Group type: EXPERIMENTAL
Intervention: 30 mg muzolimine
Number of subjects: 18

Group type: COMPARATOR
Intervention: 40 mg furosemide
Number of subjects: 18
Study: 31633742

Group type: EXPERIMENTAL
Intervention: Expert identification of interictal epileptiform discharges (IEDs) in EEGs
Number of subjects: 1051

Group type: EXPERIMENTAL
Intervention: Expert identification of whether an EEG contained any IEDs
Number of subjects: 1051

Group type: EXPERIMENTAL
Intervention: Statistical model based on waveform morphological features
Number of subjects: 1051
Study: 30320566

Group type: EXPERIMENTAL
Intervention: RIPC (Remote Ischemic Preconditioning)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RIPC+ (Remote Ischemic Preconditioning combined with electronic muscle stimulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RIPC
Number of subjects: 0
Study: 27267854

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate + prednisone (1,000 mg/d + 5 mg/d)
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate + exemestane (1,000 mg/d + 25 mg/d)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Exemestane
Number of subjects: 293
Study: 24796463

Group type: EXPERIMENTAL
Intervention: Trastuzumab administered concurrently with anthracycline-containing adjuvant regimen
Number of subjects: 109

Group type: COMPARATOR
Intervention: Trastuzumab administered sequentially with anthracycline
Number of subjects: 109
Study: 22748457

Group type: EXPERIMENTAL
Intervention: Heating humidifier with heating wire in pipeline
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine airway management (control group)
Number of subjects: 120
Study: 20544134

Group type: EXPERIMENTAL
Intervention: Delayed umbilical cord clamping at three minutes
Number of subjects: 255

Group type: COMPARATOR
Intervention: Early umbilical cord clamping within the first 15 seconds
Number of subjects: 255

Group type: COMPARATOR
Intervention: Delayed umbilical cord clamping at one minute
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: All groups (early, one minute, three minutes)
Number of subjects: 255
Study: 18771049

Group type: EXPERIMENTAL
Intervention: 100 mg twice daily of Phase III formulation
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 200 mg twice daily of Phase III formulation
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 800 mg twice daily of Phase II formulation
Number of subjects: 92
Study: 15956235

Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Valdecoxib
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Lumiracoxib
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 17
Study: 15552851

Group type: EXPERIMENTAL
Intervention: Reinfusion of drained mediastinal blood
Number of subjects: 260

Group type: COMPARATOR
Intervention: Control group (no reinfusion)
Number of subjects: 260
Study: 12176916

Group type: EXPERIMENTAL
Intervention: Intravenous cyclosporin A (CsA)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Cytarabine and infusional daunorubicin without CsA (Control)
Number of subjects: 73
Study: 10207508

Group type: EXPERIMENTAL
Intervention: GH administration (i.v. GH bolus)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Somatostatin infusion with GH administration
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: GH substitution during fasting in GH-deficient patients
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Long-term GH treatment during hypocaloric diet in obesity
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Insulin induced hypoglycemia in GH-deficient patients
Number of subjects: 36
Study: 7598298

Group type: EXPERIMENTAL
Intervention: Twice-weekly regimen of sulfadiazine (500 mg four times per day) plus pyrimethamine (25 mg) plus folinic acid (15 mg)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Daily regimen of sulfadiazine (500 mg four times per day) plus pyrimethamine (25 mg) plus folinic acid (15 mg)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Twice-weekly regimen
Number of subjects: 105

Group type: COMPARATOR
Intervention: Daily regimen
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 105
Study: 2184706

Group type: EXPERIMENTAL
Intervention: Topical TAC (0.5% tetracaine, 1:2,000 adrenalin, 11.8% cocaine)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Intradermal lidocaine
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Topical TAC
Number of subjects: 151
Study: 7468984

Group type: EXPERIMENTAL
Intervention: Electrostimulation anaesthesia (ESA)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Neurolept anaesthesia (NLA)
Number of subjects: 26
Study: 6686849

Group type: EXPERIMENTAL
Intervention: CAE + cisplatinum (CAE-P)
Number of subjects: 68

Group type: COMPARATOR
Intervention: CAE (without cisplatinum)
Number of subjects: 68
Study: 30707409

Group type: EXPERIMENTAL
Intervention: Alzheimer's disease patients
Number of subjects: 60
Study: 30231866

Group type: EXPERIMENTAL
Intervention: Levothyroxine 25 or 50 micrograms daily
Number of subjects: 291

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 291
Study: 27525699

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (SXT)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Second-generation cephalosporins (2GC)
Number of subjects: 97
Study: 24249841

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Combined Resistance Training with Pulsed Electromagnetic Fields (RTPEMF)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Pulsed Electromagnetic Fields (PEMF)
Number of subjects: 48
Study: 22727992

Group type: EXPERIMENTAL
Intervention: Bax expression in lens epithelial cells (LECs)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bcl-2 expression in lens epithelial cells (LECs)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Duration of diabetes mellitus (DM) and glycated hemoglobin (HbA1c) levels
Number of subjects: 60
Study: 20808337

Group type: EXPERIMENTAL
Intervention: 12-week intervention promoting healthier school food and changes in the school dining environment
Number of subjects: 146

Group type: COMPARATOR
Intervention: 12-week wait-listed control group
Number of subjects: 146
Study: 18195160

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Both Eplerenone and Atenolol
Number of subjects: 16
Study: 15538568

Group type: EXPERIMENTAL
Intervention: CEOP/IMVP-Dexa regimen (cyclophosphamide, epirubicin, vincristine, and prednisone/ifosfamide with systemic mesna, methotrexate, etoposide, and dexamethasone)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: CEOP/IMVP-Dexa regimen
Number of subjects: 142
Study: 12840618

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% with epinephrine (1/200,000)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Morphine 5 mg
Number of subjects: 53

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 53
Study: 10774589

Group type: EXPERIMENTAL
Intervention: Atevirdine (dose-adjusted to achieve plasma trough concentrations of 5-10 microM) and zidovudine (200 mg every 8 h) for 12 weeks (ACTG 199)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Atevirdine monotherapy with doses adjusted to achieve targeted trough plasma concentration ranges (5-13, 14-22, and 23-31 microM) for 12 weeks (ACTG 187)
Number of subjects: 50
Study: 8843126

Group type: EXPERIMENTAL
Intervention: Carboxymethylcellulose (CMC)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Hydroxypropyl methylcellulose (HPMC)
Number of subjects: 55
Study: 1632177

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium nitroprusside
Number of subjects: 0
Study: 6743720

Group type: EXPERIMENTAL
Intervention: Naloxone (2 mg/kg iv bolus infusion)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 14
Study: 30684674

Group type: EXPERIMENTAL
Intervention: OFD + aPDT (Indocyanine green dye activated with 810 nm diode laser)
Number of subjects: 20

Group type: COMPARATOR
Intervention: OFD alone
Number of subjects: 20
Study: 29424441

Group type: EXPERIMENTAL
Intervention: 1000 mg IV iron isomaltoside infusion
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 26710216

Group type: EXPERIMENTAL
Intervention: IV morphine 5 mg (group M)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg (group T)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ketorolac 60 mg (group K)
Number of subjects: 60
Study: 24687182

Group type: EXPERIMENTAL
Intervention: ACT & Check Strategy intervention
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 25
Study: 23026514

Group type: EXPERIMENTAL
Intervention: High thiamine diet (2.8 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adequate thiamine diet (1.1 mg/day)
Number of subjects: 0
Study: 20040884

Group type: EXPERIMENTAL
Intervention: Musculoskeletal therapy and physical therapy prior to weight management program
Number of subjects: 54

Group type: COMPARATOR
Intervention: Direct entry into the weight management program
Number of subjects: 54
Study: 18594319

Group type: EXPERIMENTAL
Intervention: TG4010 combined with cisplatin (100 mg/m day 1) and vinorelbine (25 mg/m day 1 and day 8)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: TG4010 monotherapy until disease progression, followed by TG4010 plus the same chemotherapy as in Arm 1
Number of subjects: 65
Study: 16026404

Group type: EXPERIMENTAL
Intervention: Open Burch colposuspension using sutures (OC)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Laparoscopic colposuspension using sutures (LCS)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Laparoscopic colposuspension using mesh and staples (LCM)
Number of subjects: 211
Study: 12422590

Group type: EXPERIMENTAL
Intervention: Azithromycin 20 mg/kg/day for the first day followed by 10 mg/kg/day for a further four days
Number of subjects: 42

Group type: COMPARATOR
Intervention: Phenoxymethylpenicillin 100,000 IU/kg/day for 14 days
Number of subjects: 42
Study: 10028084

Group type: EXPERIMENTAL
Intervention: Clarithromycin plus clofazimine with additional antimycobacterial drugs (ethambutol, ciprofloxacin, amikacin, rifabutin)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Clarithromycin plus clofazimine
Number of subjects: 8
Study: 9014762

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (observation alone)
Number of subjects: 35
Study: 1666320

Group type: EXPERIMENTAL
Intervention: Cardiovasoprotective diet (group A, n = 228)
Number of subjects: 458

Group type: COMPARATOR
Intervention: Usual diet (group B, n = 230)
Number of subjects: 458
Study: 6616153

Group type: EXPERIMENTAL
Intervention: L-phenylalanine mustard (L-PAM) as adjuvant chemotherapy
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Routine sequential chest radiography
Number of subjects: 241
Study: 29617707

Group type: EXPERIMENTAL
Intervention: Increased physical activity
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Lower BMI
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Change in physical activity through BMI change
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: BMI below the mean
Number of subjects: 692
Study: 26678445

Group type: EXPERIMENTAL
Intervention: Exercise therapy and patient education
Number of subjects: 109

Group type: COMPARATOR
Intervention: Patient education only (control group)
Number of subjects: 109
Study: 25683747

Group type: EXPERIMENTAL
Intervention: 0.3 g/kg glucose
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 0.2 g/kg glucose
Number of subjects: 34

Group type: COMPARATOR
Intervention: 15 g glucose
Number of subjects: 34
Study: 24080099

Group type: EXPERIMENTAL
Intervention: GM‐CSF plus supervised treadmill exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GM‐CSF plus attention control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus supervised exercise therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus attention control
Number of subjects: 0
Study: 20019759

Group type: EXPERIMENTAL
Intervention: FC latanoprost/timolol
Number of subjects: 270

Group type: COMPARATOR
Intervention: FC dorzolamide/timolol
Number of subjects: 270
Study: 17897931

Group type: EXPERIMENTAL
Intervention: Life skills promotion program
Number of subjects: 442
Study: 16029398

Group type: EXPERIMENTAL
Intervention: Oral transmucosal ketamine (50 mg)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Oral midazolam (0.5 mg/kg)
Number of subjects: 55
Study: 12505543

Group type: EXPERIMENTAL
Intervention: Hypertension (high blood pressure)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Hypertensive AD patients
Number of subjects: 301

Group type: COMPARATOR
Intervention: Non-demented individuals
Number of subjects: 301

Group type: COMPARATOR
Intervention: AD patients vs non-demented individuals
Number of subjects: 301

Group type: COMPARATOR
Intervention: Different populations stratified by blood pressure
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Blood pressure and AD relationship
Number of subjects: 301
Study: 10508285

Group type: EXPERIMENTAL
Intervention: Gadolinium (Gd)‐chelate contrast agents used in MRI
Number of subjects: 0
Study: 8554132

Group type: EXPERIMENTAL
Intervention: Operative closed-suction drainage
Number of subjects: 120

Group type: COMPARATOR
Intervention: No operative closed-suction drainage
Number of subjects: 120
Study: 2068474

Group type: EXPERIMENTAL
Intervention: Combination of aztreonam and cloxacillin/oxacillin
Number of subjects: 92

Group type: COMPARATOR
Intervention: Combination of tobramycin and a cephalosporin
Number of subjects: 92
Study: 6683538

Group type: EXPERIMENTAL
Intervention: 1500 mg calcium dobesilate
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 1000 mg calcium dobesilate
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 500 mg calcium dobesilate
Number of subjects: 52

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 52
Study: 30706796

Group type: EXPERIMENTAL
Intervention: μm‐PEA 600 mg twice a day for 1 week
Number of subjects: 22
Study: 29980202

Group type: EXPERIMENTAL
Intervention: NEOSORB® Plus
Number of subjects: 100

Group type: COMPARATOR
Intervention: NEOSORB®
Number of subjects: 100
Study: 26190371

Group type: EXPERIMENTAL
Intervention: Lunch is in the Bag program
Number of subjects: 577
Study: 23355152

Group type: EXPERIMENTAL
Intervention: EGD-colonoscopy sequence
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Colonoscopy-EGD sequence
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 1100
Study: 21427273

Group type: EXPERIMENTAL
Intervention: Constraint-induced movement therapy (CIMT)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Bimanual training (BIM)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 64
Study: 19477400

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Baseline measures of mechanical dyssynchrony
Number of subjects: 71
Study: 17233232

Group type: EXPERIMENTAL
Intervention: R&S + AaR
Number of subjects: 1202

Group type: COMPARATOR
Intervention: R&S
Number of subjects: 1202
Study: 15566928

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 0
Study: 11561312

Group type: EXPERIMENTAL
Intervention: Artificial nitric baths (n = 44, group 1)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Artificial nitric baths plus bicycle exercise (n = 37, group 2)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Fresh water baths (n = 30, group 3)
Number of subjects: 111
Study: 9761098

Group type: EXPERIMENTAL
Intervention: Double bolus urokinase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Front-loaded alteplase
Number of subjects: 0
Study: 7760988

Group type: EXPERIMENTAL
Intervention: Minaprine (200 mg)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Imipramine (50, 75, 100 mg)
Number of subjects: 67
Study: 2397553

Group type: EXPERIMENTAL
Intervention: Modified Xiao‐Jin Pills (MXJP)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no MXJP)
Number of subjects: 72
Study: 81155

Group type: EXPERIMENTAL
Intervention: Fenoprofen (200 mg) and paracetamol (500 mg) given 3 to 4 times daily for a period of 4 to 14 days
Number of subjects: 75

Group type: COMPARATOR
Intervention: Dihydrocodeine tartrate (30 mg)
Number of subjects: 75
Study: 31432379

Group type: EXPERIMENTAL
Intervention: PAX Good Behavior Game (PAX GBG)
Number of subjects: 708
Study: 30833647

Group type: COMPARATOR
Intervention: Capecitabine for 6 months (2500 mg/m2/day for 14 out of 21 days)
Number of subjects: 1306

Group type: EXPERIMENTAL
Intervention: Capecitabine for 12 months (2500 mg/m2/day for 14 out of 21 days)
Number of subjects: 1306

Group type: COMPARATOR
Intervention: Capecitabine for 6 months
Number of subjects: 1306

Group type: EXPERIMENTAL
Intervention: Capecitabine for 12 months
Number of subjects: 1306
Study: 25481073

Group type: EXPERIMENTAL
Intervention: rTMS over the right precuneus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition without rTMS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: rTMS over the left precuneus
Number of subjects: 0
Study: 21837551

Group type: EXPERIMENTAL
Intervention: Process Assessment of the Learner (PAL) lesson plans, specifically Lesson Sets 4 and 7, conducted via small groups (3-6 students) twice a week for 12 weeks.
Number of subjects: 138

Group type: COMPARATOR
Intervention: Business-as-usual conditions (control group)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Typical group (n=67)
Number of subjects: 138
Study: 21689916

Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 983
Study: 19757877

Group type: EXPERIMENTAL
Intervention: Korean folksongs rated by young Koreans
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Korean folksongs rated by young Americans
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Korean folksongs rated by older Koreans
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Korean folksongs rated by older Americans
Number of subjects: 4
Study: 16499758

Group type: EXPERIMENTAL
Intervention: Active DC polarization (20 min, 1 mA)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Active DC polarization
Number of subjects: 19
Study: 12949691

Group type: EXPERIMENTAL
Intervention: Proproten-100
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phenazepam
Number of subjects: 0
Study: 10669276

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation on bilevel positive airway pressure (NIV-2P)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Incentive spirometry (IS)
Number of subjects: 96
Study: 9039714

Group type: EXPERIMENTAL
Intervention: Continuous and intermittent use of GTN patches
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Changing to a different transdermal system
Number of subjects: 320
Study: 1435283

Group type: EXPERIMENTAL
Intervention: Functional-ecological assessment procedure
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standardized assessment procedure
Number of subjects: 38

Group type: COMPARATOR
Intervention: Combined assessment package
Number of subjects: 38
Study: 3882216

Group type: EXPERIMENTAL
Intervention: Short-term preoperative radiotherapy (RT-group) with 25 Gy (2500 rad) over 5 days
Number of subjects: 352

Group type: COMPARATOR
Intervention: Surgical treatment only (S-group)
Number of subjects: 352
Study: 31203032

Group type: EXPERIMENTAL
Intervention: Individual- and neighborhood-level environmental factors
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Improved neighborhood-level conditions related to social and physical disorder
Number of subjects: 450
Study: 30062982

Group type: EXPERIMENTAL
Intervention: Presence of another person near the handwashing location
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Presence of both child(ren) and adult(s) or just children
Number of subjects: 20

Group type: COMPARATOR
Intervention: No presence of another person
Number of subjects: 20
Study: 26909534

Group type: EXPERIMENTAL
Intervention: HRV-guided experimental training (EXP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional predefined training (TRAD)
Number of subjects: 40
Study: 24909206

Group type: EXPERIMENTAL
Intervention: Closed-loop therapy with meal announcement
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional pump therapy
Number of subjects: 12